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ABSTRACT
Nonadherence to medical regimens is a critical behavioral threat to the health
of HIV-infected individuals. Patients cannot benefit from increasingly efficacious
treatments for HIV/AIDs unless they adhere to them. Consistent medical care plays
a central role in prolonging life and enhancing quality of life for these individuals. It
is therefore essential to understand why many patients do not return reliably for
medical services. However, little research has focused on the development of
empirically based models of HIV-related nonadherence. Thus, the primary purpose
of the present study was to identify factors predictive of HIV-related nonadherence to
medical appointments. Demographic, medical care, and psychosocial factors were
identifîed that prospectively predicted percentage of scheduled H IV clinic
appointments no-showed by outpatients. The results of this study indicated that
greater nonadherence to ouq>atient appointments was associated with younger age,
minority background, less severe illness, and lower perceived social support.
Individuals from minority backgrounds and younger age groups were found to have
higher rates of nonadherence to H IV treatment demands. Nonadherence was also
demonstrated to be problematic early in the disease course. From the perspective of
potential psychosocial interventions, it was particularly interesting that higher levels
of perceived social support were associated with less outpatient visit nonadherence.
Practical and theoretical implications of these findings are discussed in light of recent
medical advances.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

INTRODUCTION
Since the Grst cases were identified in 1981, AIDS has been fearfully
heralded as the disease of the century and a societal problem of paramount
importance for our time. As we approach the twenty-first century, HTV and AIDS
have already reached pandemic proportions (Anderson & May, 1992; Mann,
Tarantola, & Netter, 1992; Mann & Tarantola, 1996). The major risk Actors for
H IV infection are behaviors which can be changed. Consequently, the emphasis of
much psychological research is on the prevention of high risk sexual and druginjecting behaviors (Kelly, 1995). Despite attempts to mobilize public health
resources, prevention efforts have not stopped H IV from reaching the status of a
global epidemic. While HIV risk behavior reduction continues to be a pressing issue
amenable to behavioral study and intervention, the increasingly high prevalence of
H IV also points to the need for salient investigations of health behaviors among those
already infected with H IV.
Nonadherence to medical regimens is one of the most pervasive and
problematic behavioral threats to the health of chronically ill individuals (DunbarJacob, Burke, & Puczynski, 1995). Patients cannot benefit optimally from medical
care if they do not adhere to their recommended medical treatments. Although the
progression from H IV infection to AIDS is irreversible, beneficial medical
interventions are currently available. Medical management of this chronic, lifethreatening syndrome entails regular medical monitoring and ongoing preventive and
curative interventions.

Consistent medical care plays a central role in prolonging

I
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life, improving general health, and enhancing overall quality of life among
individuals at each phase of the HIV/AIDS spectrum. Nonadherence to HIV-related
medical regimens may therefore pose a very serious health problem (Chesney &
Folkman, 1994).

Unfortunately, few empirical studies have sought to investigate the

magnitude of this problem or to explore biopsychosocial factors which may
contribute to medical nonadherence among individuals with HIV/AIDS. The
deleterious effects of medical nonadherence on the health and well-being of H IVinfected patients might be mitigated by appropriate intervention. Current knowledge
regarding psychosocial and medical care factors most relevant to HIV-related
nonadherence, however, is not sufficiently well developed to serve as a firm base for
corrective measures. Thus, research to address the issue of nonadherence among this
growing medical population is clearly needed.
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HIV
To fully appreciate the need for addressing treatment nonadherence among the
HIV-infected, a broad understanding of HIV is essential.

The socio-culturai,

biomedical, and psychosocial aspects of HIV infection and its progression to AIDS
w ill therefore be reviewed.
Scope o f the Epidemic
Worldwide, as many as 20.3 million adults were estimated to be HIV-infected
in 1996 and by the end of this century the number is likely to reach 60-70 million
(Mann & Tarantola, 1996; World Health Organization, 1995). The transmission of
human immunodeficiency virus (H IV ) and the prevalence of acquired
immunodeficiency syndrome (AIDS) have continued to expand, and now impact
nearly every country in the world (Mann & Tarantola, 1996). In the United States
alone, more than half a million cases of AIDS had been reported to the Centers for
Disease Control by the end of 1996 (CDC, 1997). AIDS has been the leading cause
of death among American men aged 25-44 since 1992 (CDC, 1993). By 1995,
AIDS caused 19% of all American deaths in the 25-44 age range (CDC, 1997). The
scope of the HIV-AIDS epidemic can best be conceptualized as a conglomerate of
subepidemics affecting an increasingly broad array of high risk populations
(Kalichman, 1995). After the AIDS surveillance case definition (i.e., the set of
diagnostic criteria disseminated by the CDC and used to track the epidemic) was
expanded in 1993, the most rapidly growing subpopulations of AIDS cases were
among adolescents, women, racial and ethnic minorities, and individuals infected
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through drug injection or heterosexual contact (CDC, 1995b; CDC, 1997; Karon,
Rosenberg, McQuillan, Khare, Gwinn, & Petersen, 1996).
H IV and AIDS have a devastating impact on an increasingly broad
sociodemographic range of individuals. The rate of HTV infection among any given
segment of the population is determined by the likelihood of the virus being
transmitted to uninfected individuals from those who are already infected. The
principle routes of HIV infection among adults are via fluid-exchanging sexual
activi^ and contact with infected blood, either by transfusion or contaminated
injection equipment (Glasner & Kaslow, 1990). The virus is transmitted most
efficiently through the behaviors of anal intercourse, vaginal intercourse, and by
sharing drug-injecdon needles. Thus, individuals who engage in relatively high rates
of these behaviors and/or with a wider network of potentially seropositive partners
are at highest risk for HIV infection. The earliest subpopulations infected in the
United States were male homosexuals and hemophiliacs who received blood product
transfusions from multiple donors.

Injection drug-users who share needles

frequently and heterosexuals who engage in unprotected vaginal or anal intercourse
with multiple partners are at the highest risk for infection among these
subpopulations. Multiple risk factors and cross-modal HIV transmission (i.e., druginjectors infecting sexual parmers) are increasingly common (CDC, 1995a).
Currently, heterosexual contact accounts for the majority of AIDS cases worldwide
and homosexual contact accounts for the largest proportion of AIDS cases in the
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U.S., with infection rates continuing to grow across diverse segments of American
society (CDC, 1997; Kalichman, 1995; Karon et al., 1996).
Pathogenesis and Clinical Course
Viral characteristics.
H IV is a retrovirus. Retroviruses have a genetic core of RNA which is
converted into viral DMA and integrated with the DNA of infected host cells. This
means that a retrovirus such as H IV is able to "hide” safely within a host cell for
long periods of time and is capable of using the cell's resources to replicate itself as
a free virus (Fauci, 1988). HTV has the highest binding affinity for cells with
antigen receptor cites classified as cluster determinant 4 (CD4) surface molecules
(Fauci, 1988). Thus, HIV selectively integrates and destroys CD expressing cells
4

such as T-helper lymphocytes. T-helper cells, the primary pathogenic target of HIV,
play a crucial role in immune functioning. CD T-helper cells serve to coordinate
4

immune system responses by stimulating the B lymphocytes responsible for
producing antigens to combat foreign agents in the body. Depletion of T-helper
lymphocytes is the immunologic result of H IV infection that is primarily responsible
for the pervasive immunosuppression characteristic of AIDS (Fauci, 1988).
In addition to the direct effects of H IV on T-helper cells, the virus has other
indirect immunocompromising effects. O f particular importance, T-helper cells
mediate the activity of natural killer cells and T-suppressor cells. Thus, their
destruction has a deleterious efiect on the abili^ of the immune system to fight
infection-causing and tumor-causing agents or to modulate immune responses when
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these threats diminish (Devita, Heilman, & Rosenberg, 1985; Fauci, 1988). Also,
H IV either binds to, or is "swallowed” by, CD expressing monocyte macrophages.
4

This is important because infected macrophages are prevented from acting as
phagocytes which engulf and kill microorganisms, and because H IV can be "safely"
transported to the brain, lungs, and other parts of the body once within a macrophage
(Rosenberg & Fauci, 1991). Thus, H IV impairs immune functioning both directly
and indirectly, leaving infected individuals vulnerable to attack from a number of
opportimistic infectious diseases that would otherwise be suppressed by the immune
system.
Stages of disease progression.
H IV infection begins a chronic, fluctuating disease course that eventually ends
in AIDS-related illness and death (Schecter et al., 1990). Shortly after H IV
transmission, an acute period of retroviral infection may manifest itself in some
individuals as a 1-2 week mononucleosis-like syndrome (Tindall et al., 1992).

HIV

infection then follows a variable clinical course characterized by: (a) a lengthy
"silent" or asymptomatic period, (b) an immunocompromised or symptomatic phase,
and (c) and an advanced stage in which AIDS-related illnesses are likely to be
manifested.

The progression of H IV to AIDS has been classified in various ways as

medical knowledge has increased (CDC, 1987). A useful system for classifying the
HIV/AIDS spectrum is m describe stages of disease progression on the basis of Thelper cell counts (Bartlett, 1993; Clement & Hollander, 1992). Individuals with Tcell counts higher than 500 cells per mm^ may be considered asymptomatic, while
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people with T-cell counts from 200 to 500 cells/mm^ can be described as
immunocompromised. T-helper lymphocyte counts below 200 cells/mm^ are within
the AIDS diagnosis range (CDC, 1992), with AIDS-related illnesses being most
prevalent when T-cell counts fall below 100 cells/mm^. Although T-cell counts are
considered a fairly reliable marker of disease progression, the rate of decline
(typically a reduction of 50-100 cells/mm^ per year) may differ markedly across
individuals, with the time from infection to AIDS varying from I to 15 years
(Kalichman, 1995).
Current CDC AIDS case definition criteria include evidence of either immune
system deterioration following H IV infection (T-cell counts below 200 cells/mm^ ) or
the presence of any of 25 AIDS-defining conditions (CDC, 1992). While most
AIDS-related complications are due to the effects of immunosuppression (i.e..
Candidiasis infection, pneumocystis carinii pneumonia (PCP), mycobacterium
tuberculosis, invasive cervical cancer, Kaposi's sarcoma), some are attributed to
direct H IV infection of various organs and systems (e.g., lymph nodes, lungs, brain).
Despite the variable patterns of AIDS-related illnesses across individuals, each case
of AIDS has one commonali^. Infections or malignancies that would normally be
rare, or even innocuous, become life-threatening in the free of a severely depleted
immune system.
Medical treatment and proohvlaxis.
Given the natural history of HIV and the current status of medical
intervention technology, the primary aims of medical management are (a) to slow the
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loss of T-helper lymphocytes, (b) to prevent and treat opportunistic infections, and
(c) to prevent the growth of malignancies. Rapid advances in the medical
management of H IV have led to increased life expectancies for today's HIV-infected
patients. For example, the most recent reports from the Centers for Disease Control
and Prevention attribute the first ever decline in U.S. AIDS-related deaths in 1996 to
the life-prolonging effects of antiretroviral and anti-infective medications that were
standard clinical care by the 1990's (CDC, 1997). Current standards of care dictate
that medical management should begin immediately after H IV diagnosis.
Frequent monitoring of immune status is recommended. Regular lymphocyte
counts and measures of plasma viral load (i.e., blood levels of HIV RNA) serve as
markers of disease progression and provide a partial basis for deciding when to begin
pharmacological interventions designed to slow this progression (Carpenter et al.,
1996). Initiation of antiretroviral treatments such as zidovudine (AZT) or
combination therapies are generally suggested when CD« counts fall below 500
cells/mm^ (Marchland, Klein, & Struble, 1996; U.S. Department of Health and
Human Services, 1994). Nucleoside and protease inhibitor combination therapies act
to suppress viral replication of H IV, and thus serve to slow T-cell decline and to
minimize opportunistic diseases (Bartlett, 1993; Carpenter et al., 1996).
To prevent opportunistic infections and malignancies, a number of routine
medical examinations are also recommended (U.S. Department of Health and
Human Services, 1994). Oral and eye examinations are required to detect mouth and
ocular lesions indicative of Kaposi's sarcoma or opportunistic infections such as
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cytomegalovirus (CMV) retinitis.

For women, regular gynecologic examinations

are suggested (e.g., for candidiasis and cervical cancer detection). Other H IVrelated illnesses requiring routine medical screening include mycobacterium
tuberculosis and syphilis.

In addition to the recommended medical screening

protocols, another important component of medical management for H IV involves the
prophylactic pharmacologic treatment o f the most common opportunistic infections
(U.S. Department of Health and Human Services, 1994). For example, prophylactic
treatments including aerosolized pentamidine and bactrim have significantly reduced
rates of AIDS-related PCP (Osmond, Charlebois, Lang, Shiboski, & Moss, 1994).
In summary, although the progression to acquired immunodeficiency
syndrome cannot yet be reversed, routine medical care is essential for prolonging
life, improving general health, and alleviating suffering among individuals at each
phase of the HIV/AIDS spectrum. Optimal management of this chronic syndrome
entails consistent medical monitoring and intervention.
Psvchosocial Aspects of HIV
There are many characteristics of H IV infection which may impact
psychosocial adjustment. An incurable prognosis and a chronic, fluctuating disease
course combine with social stigmatization to pose complex challenges to the coping
resources of infected individuals. The course of adjustment may include distress
reactions (i.e., denial, depression, hopelessness, anxiety, somatization, anger, guilt)
as well as efforts to reframe HIV-related experiences and to regain emotional
equilibrium (i.e., searches for meaning, control, and support; renewed self-efficacy.
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optimism and spiritualiQr) (Borden, 1991; Holland & Tross, 1985; Kalichman, 1995;
Kalichman & Sikkema, 1994; Kelly & St. Lawrence, 1988; Ostrow et al., 1989;
Pakenham, Dadds, & Terry, 1994; Siegel & Krauss, 1991). Psychosocial
functioning may vary across phases of the disease (Kessler et al., 1988) and to some
extent across different demographic groups (Ostrow et al., 1991).
Psychological reactions to H IV often tend to model the fluctuating patterns of
the disease process itself (Chesney & Folkman, 1994; Kalichman, 1995). When
individuals initially learn of their H IV seropositive status they may react with shock,
disbelief, denial, grief, depression, hopelessness, guilt, anger, or fear (Cleary et al.,
1993; Chesney & Folkman, 1994; Ostrow et al., 1989). This initial distress often
fades during the asymptomatic phase of infection and reemerges with the onset of
HIV-related symptoms (Blaney et al., 1990; Rabkin et al., 1990; Kelly et al., 1993).
Thus, adjustment difficulties are likely to reoccur just as immimologic functioning
begins to decline noticeably and to necessitate increased medical monitoring and
management.

New physical symptoms or information about "benchmark" declines

in CD coimts (i.e., dropping below cell counts of 500 or 200) may serve to trigger
4

exacerbations in psychological distress (Ostrow et al., 1989). As the disease
progresses to AIDS, patients gradually experience an inevitable series of losses
threatening every aspect of their quali^ of life, from leisure and work activities to
physical well-being and mental health (Chesney & Folkman, 1994; Kelly & St.
Lawrence, 1988). The reduction in energy, loss of weight and attractiveness,
declining cognitive and physical abilities, and general curtailment of activities which
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can accompany AIDS-related diseases may be associated with feelings of acceptance
or even hopelessness (Reed, Kemeny, Taylor, Wang, & Visscher, 1994; Rabkin et
al., 1990). The parallel phases of psychological and physical symptoms outlined
thus far, presuppose diagnostic notification early in the infection process. The
psychological impact may be condensed, and potentially more devastating, if
individuals are already sick with an AIDS-related disease when they learn of their
status (Kalichman, 1995).
Depression is perhaps the most pervasive, and certainly the most commonly
studied, distress reaction among HIV-infected individuals (Kalichman & Sikkema,
1994). Although not everyone responds to HIV with clinically significant distress
(Perry, Jacobson, & Fishman, 1990; Williams et al., 1991) the most prevalent
psychiatric diagnosis among H IV populations is adjustment disorder with depressed,
anxious, or mixed features (O’Dowd, Natali, Orr, & McKegney, 1991; Chuang,
Jason, Pajurkova, & G ill, 1992). Many investigators have found that HIV-infected
individuals from a varieQr of backgrounds (i.e., drawn from homosexual, minority,
hemophiliac, military, blood donor, and heterogenous samples) report clinically
significant levels of depression (Atkinson et al., 1988; Bernstein et al., 1993;
Cochran & Mays, 1994; Dew, Ragni, & Nimorwicz, 1990; Kelly et al., 1993;
Rabkin et al., 1991; McClure et al., 1996; Miller & Riccio, 1990). However, there
are methodological issues which limit the validity of many H IV depression studies
(Kalichman & Sikkema, 1994). Most importantly, measurement of depression
among infected individuals may be confounded by overlapping physical symptoms of
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HIV and medication side effects such as Wgue, anorexia/weight loss, impaired
concentration, or night sweats/insomnia (Belkin, Fleishman, Stein, Piette, & Mor,
1992; Drebing et ai., 1994). Confounds can be minimized by removing HIV-related
somatic symptoms from depression measures either statistically (Kelly et al., 1993)
or via omission (Burrack, Barrett, Stall, Chesney, Ekstrand, & Coates, 1993). Such
procedures leave intact key affective and cognitive components of depression, such as
hopelessness.
Hopelessness is arguably one of the most salient aspects of depressive
reactions among those infected with HIV (Kalichman, I99S). Hopelessness (i.e.,
severe pessimism about the future) may be an especially relevant component of
HIV/AlDS-related distress because of the terminal prognosis, uncertain disease
course, and social isolation associated with the disease (Kalichman, 1995; Rabkin,
Williams, Neugebauer, Remien, & Goetz, 1990). In Act, hopelessness was found to
be significantly elevated among HIV-positive individuals as compared to both cancer
patients (Kelly, Dunne, & Raphael, 1991) and seronegative hemophiliacs (Catalan,
Klimes, Bond, Day, Garrod, & Rizza, 1992). Unlike many indices of depression
that overlap with HIV-related physical symptoms, measures of hopelessness tap
primarily cognitive and affective domains of distress. For example, beyond the
contributions of HIV status and symptom frequency, a relationship between
hopelessness and depression has been demonstrated (Rabkin et al., 1990). Among
HIV-infected gay men in a major epicenter, Rabkin and colleagues (1990) found that
24% of their sample obtained moderate to severe elevations on the Beck
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Hopelessness Scale. Another study of hopelessness among HIV-positive
hemophiliacs yielded similar results (M iller and Riccio, 1990). In general,
investigations o f psychosocial functioning have found hopelessness positively related
to psychological morbidity and negatively related to overall psychological adjustment
among HIV-positive individuals (Kelly, Dunne, & Raphael, 1991; Catalan et al.,
1992). Greater levels of hopelessness have also been associated with decreased
social support (Rabkin et al., 1990; Zich & Temoshok, 1987).
Attempts to manage the demands associated with H IV can lead to positive and
adaptive responses as well as to emotional distress. For example, interview data
indicates that many gay men report positive changes associated with H IV infection,
including reprioritizing life goals, increasing commitment to health-related behaviors,
and strengthening social relationships (Borden, 1991). More empirical evidence also
links social support and coping to positive adjustment among those infected with
HFV. A recent study suggested that social support was relatively more strongly
associated with disease status and social adjustment to illness, while coping strategies
involving optimism, control, action, and interpersonal coping were associated with
higher levels of both illness-related and global psychological health (Pakenham,
Dadds, & Terry, 1994). Another recent investigation suggested that the use of
spiritual coping may potentially broaden sources of support and improve positive
adjustment to H IV (Somlai et al., 1996). Optimistic beliefs about the future
consequences of H IV, even when unrealistic, have also been associated with better
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psychological adjustment, with more active coping, and with maintenance of health
behaviors (Taylor e ta l., 1992).
Clearly, the psychosocial changes experienced by HIV-infected patients
interact with other dimensions of their quali^ of life and with health-related
behaviors. For example, Siegel and Krauss (1991) conceptualized adjustment to HIV
in terms of five challenges which, according to several coping theorists (Cohen &
Lazarus, 1979; M iller, 1983) are faced by all chronically ill individuals. These
essential adaptive tasks include; (a) decreasing threatening conditions and increasing
positive outcomes [complying with prescribed regimens, altering lifestyles, acquiring
self-care skills], (b) dealing with negative events and expectations [combatting
stigma, confronting the inevitability of death, managing physical discomfort, grieving
over losses], (c) maintaining self-esteem [regaining a sense of control and normalcy,
maintaining a positive self-image], (d) stabilizing emotions [maintaining hope], and
(e) maintaining positive social relationships [adjusting to changes in relationships and
roles] (Cohen & Lazarus, 1979; Siegel & Krauss, 1991).

Thus, behavioral

responses to HIV, as with any chronic illness, may be influenced by complex
interactions between disease-related demands, emotional distress, support resources,
and patterns of coping.
The psychological and social sequelae of H IV and AIDS may have an
important impact on behavioral responses to the disease. Adequate psychosocial
functioning is likely to be associated with more active involvement in medical
management (Siegel & Krauss, 1991; Namir et al., 1987). Consistent medical care

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

15
is crucial for prolonging life and improving qualiQf of life among people with HIV
infection. Thus, psychosocial influences on patients' seeking treatment and adhering
to prescribed medical regimens are arguably an issue of grave importance.
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NONADHERENCE
Nonadherence among individuals with HIV and AIDS must be viewed within
the context o f chronic illness and nonadherence to medical regimens in general.
Therefore, a brief overview of the field o f medical noncompliance will first be
presented.
Definition o f Nonadherence
Broadly defined, the terms nonadherence and noncompliance denote the
degree to which behavior fails to coincide with medical or health-related advice.
Although "nonadherence" and the older label of "noncompliance" are synonyms
describing this pervasive threat to health care, nonadherence is the term that is now
advocated by some researchers (Dunbar-Jacob, Burke, & Puczynski, 1995) because it
has more of a collaborative connotation for describing patient and physician
interactions (Gerber, 1986). Nonadherence can be operationally defined in a variety
of ways. For example, nonadherence classifications may refer to any minute
deviation from a treatment regimen, or to adherence percentages below 80% of
prescribed treatment demands (Carr and Maxim, 1983). Definitions of nonadherence
which express the concept as the percentage of total regimen followed are widely
regarded as the most valid and sensitive measure, and may allow adherence
assessment to lead most easily to measurable interventions (Dunbar, 1979).
Nonadherence and Chronic Illness
Nonadherence is a major health care problem among chronically and
terminally ill patients (Gerber, 1986, German, 1988). The therapeutic benefits of

16
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health care are commonly jeopardized by chronically ill individuals because they do
not consistently adhere to prescribed medical regimens (German, 1988; DunbarJacob, Burke, & Puczynski, 1995). The prevalence of medical nonadherence has
been widely documented and has remained at a

6

irly stable rate for more than two

decades (Dunbar-Jacob, Dwyer, & Dunning, 1991). Estimates indicate that half of
medical patients do not take prescribed medications, that 20-80% drop out of long
term treatments, and that as many as 20-50% of medical t^pointments are missed
(Becker, 1985; Sackett, 1976; Sackett & Snow, 1979; Turk, Meichenbaum, &
Genest, 1983). Every patient is at risk for nonadherence. At some time in the
course of treatment, as many as 80% of medical patients may be at least partially
nonadherent (Dunbar-Jacob, Burke, & Puczynski, 1995).

Nonadherence has a

significant impact on medical care among individuals of all ages and sociocultural
groups. Although socio-economic status has been shown to influence rates of
nonadherence in some studies, the findings are equivocal and appear to vary across
diseases (Tagliacozzo & Ima, 1970; Gravely & Oseasohn, 1991; Roberson, 1992).
Overall, the literature suggests that: (a) patients' demographic characteristics are the
least relevant to nonadherence, (b) psychosocial factors are understudied and
inconsistently associated with nonadherence, and (c) specific characteristics of
medical regimens are the most clear predictors of low adherence (Dunbar-Jacob et
al., 1995).
Determinants of nonadherence may depend to some extent on the medical
population being studied, the definition of adherence employed, and the type of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

18
medical regimen prescribed (Carr and Maxim, 1983; Dunbar-Jacob, Burke, &
Puczynski, 1995; Sherbourne, Hays, Ordway, Dimatteo, & Kravitz, 1992).
Characteristics of medical regimens that have most consistently been found related to
nonadherence include greater complexity of interventions (Agras, 1989; Goodall &
Halford, 1991; Blackwell, 1992) and greater duration of interventions (Agras, 1989;
Richardson, 1986; Goodall & Halford, 1991). Complex interventions may require
too much behavior change for patients to adhere to the regimen (Anderson, 1990).
Likewise, the demands of long term maintenance of treatment regimens exceed many
patients' tolerance for health-related behavior change.

Nonadherence tends to

increase over time and it is also likely to increase if a treatment regimen entails
unpleasant side-effects (Agras, 1989; Blackwell, 1992). Characteristics of certain
diseases have also been hypothesized to be linked to adherence problems. For
example, if patients are asymptomatic or have difficulty identifying signs of
improved health, adherence to prophylactic regimens may be less likely to be
maintained.

The relevance to nonadherence of psychosocial factors such as social

support, avoidant coping strategies, and depressive and anxiety symptoms also appear
to vary across different chronic diseases (Blumenthal et al., 1982; Boyer et al., 1990;
Kulik & Mahler, 1993; Dunbar-Jacob et al., 1995; German, 1988; Kiecolt-Glaser &
Williams, 1987; Sherbourne et al., 1991). Thus, individuals with chronic illnesses
which are likely to threaten psychosocial functioning or to require complex, long
term, or prophylactic medical care may potentially be at high risk for medical
nonadherence.
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Nonadherence and HIV
Unfortunately, both the recommended regimens for medical management of
HIV/AIDS and the disease process itself possess many characteristics which have
been suggested as predictors of nonadherence (Chesney & Folkman, 1994; DunbarJacob et al., 1995). H IV is a highly stigmatized virus that affects socially
disenfranchised individuals in high proportions. The disease course begins with a
lengthy asymptomatic phase and is often perceived as uncertain or uncontrollable.
Treatment regimens offer no hope for a cure and frequently require adherence to
lengthy, complex treatments which may be prophylactic or entail negative side
effects. Particularly high rates of medical nonadherence have been documented
among patients both early and late in the disease course. For example, rates of
treatment refusal among hospitalized AIDS patients have been reported to reach 90%
(Blumenfield, Milazzo, & Wormser, 1990), asymptomatic research participants have
been found to drop out of AZT trials at a rate of nearly 30% (Fischl et al., 1990),
and among H IV outpatients rates of 23% nonadherence to AZT regimens have been
described (Samet et al., 1992).

To put these nonadherence rates into perspective,

70% of leukemia inpatient controls refused some treatment in Blumenfîeld's (1990)
study, and attrition rates for clinical trials treating other chronic diseases (e.g., beta
blockers for cardiovascular disease) are generally less than 10% (Bell et al., 1985; as
cited in Chesney & Folkman, 1994).
Only a very small number of studies have directly explored adherence to HIV
medical interventions. This is surprising given the weight medical care providers
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working with HIV-infected patients appear to place on this issue, and given the
potential impact of treatment adherence on both the quality and quantity of life
throughout the HIV/AIDS disease spectrum. Some research has explored adherence
to specific HIV-related pharmacologic regimens. Opravil, Weber, Ledergerber,
Speich, Siegenthaler, and Luthy (1990) found a relationship between PCP relapse
and nonadherence to pentamidine prophylaxis among AIDS patients. Those who
failed to adhere to their prophylactic treatment regimen displayed higher pneumonia
relapse rates than did adherent patients. Other studies have documented that
nonadherence and drop-out rates among AZT drug trial participants are highly
problematic (e.g., Fischl et al., 1990; Morse, Simon, Cobum, Hyslop, Greenspan,
& Balson, 1991). Several recent and preliminary studies have examined
nonadherence to H IV outpatient appointments. Using archival data collected from
two public H IV clinics, Kissinger and colleagues (1995) found that 15% of clients
failed to attend the ideal number of visits suggested by treatment guidelines (i.e.,

1 - 6

appointments during a -month period depending on disease status). In this study,
6

patients who missed appointments were more likely to be immunocompromised, to
be African-American, and to have a history of IV drug use (Kissinger, Cohen,
Brandon, Rice, Morse, & Clark, 1995). Similarly, a pilot study conducted at a
public hospital in Baton Rouge, in which nonadherence was measured in terms of the
percentage of actual appointments scheduled, found that 36% of appointments were
failed (Catz et al., 1995).

The same rate of appointment fitilure was documented
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during a randomly sampled one-week period by Shelton and colleagues (1993) among
women scheduled to attend an H IV clinic at a large Miami hospital.
Even fewer studies have examined the role of psychosocial factors in the
prediction of HIV-related nonadherence. O f the limited studies identified in a
comprehensive review of the literature, none empirically investigated this research
question with methodological rigor.

For example, although hopelessness was

proposed as a causal factor for medical nonadherence in a study in which AIDS
patients' treatment refusal rates were found to be four times higher than leukemia
patients, this hypothesis was not empirically tested by the researchers (Blumenfield,
Milazzo, & Wormser, 1990). Morse and colleagues (1991) used a vaguely defined
methodology of questionable validity to evaluate asymptomatic HIV-positive subjects'
adherence within an experimental drug protocol. Research participants were
identified as compliant or noncompliant to the protocol on the basis of nurses' rank
ordering of subjects in terms of an undefined level of perceived "compliance." The
authors interpreted their results as suggesting that research subjects perceived as most
compliant lived further from the treatment site, didn't live alone, viewed nursing
staff as supportive, and were more likely to depend on a specific person for social,
economic, and emotional support (Morse et al., 1991). In another exploratory study,
Shelton and colleagues (1993) interviewed four pregnant, seropositive, AfricanAmerican women and their families for the purpose of identifying factors
contributing to their medical nonadherence. They concluded that transportation,
child care, concern for the health of the fetus, the presence of concerned family
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members, and substance abuse were most relevant to health care behaviors among
these women (Shelton, Marconi, Pounds, Scopetta, O'Sullivan, & Szapocznik,
1993). In sum, several psychosocial Actors (e.g., hopelessness and social support)
have been proposed to contribute m medical nonadherence among HIV-positive and
AIDS patients (Blumenfield, Milazzo, & Wormser, 1990 ; Morse et al., 1991;
Shelton et al., 1993). Unfortunately, the studies investigating these Actors have thus
far been limited in both scope and methodology.
Given the pauci^ o f investigations integrating the adherence and H IV
literatures, the most pertinent information from each area w ill be presented below in
an attempt to elucidate relevant factors likely to impact nonadherence to HIV-related
medical care. A discussion of six psychosocial and medical care factors thought to
be most pertinent will be followed by a brief discussion of how adherence should be
measured in H IV outpatient populations.
Social support.
Social support has been described as one of the few psychosocial variables
clearly implicated in medical nonadherence (Gravely & Oseasohn, 1991). Generally
speaking, individuals with poor social support are less likely to be adherent than
individuals with good social support systems (Agras, 1989).

For example, in a

longitudinal study of patients with three different chronic medical conditions
(hypertension, diabetes, and heart disease), Sherbourne, Hays, Ordway, Dimatteo, &
Kravitz (1992) found a strong link between improved diabetic adherence and
increased quality (but not quantity) of social support. Likewise, greater emotional

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

23
support from spouses was a signifîcant predictor of lower emotional distress, better
quality o f life perceptions, and adherence to lifestyle changes among cardiac surgery
patients (Kulik & Mahler, 1993).

Similarly, social support was demonstrated to be

a good predictor of medical adherence, operationalized in terms of both pill-count
ratios and percentage of kept appointments, among patients with hypertension
(Stanton, 1987). Thus, a positive relationship between social support and adherence
has been a fairly consistent finding across a variety of chronic illness samples.
Kalichman (1995) suggests that social support leads to treatment seeking
behavior and to enhanced treatment adherence among HIV populations, just as it has
been demonstrated to promote these health-related behaviors in general (House,
Landis, & Umberson, 1988).

Patients who have any chronic disease may require

extra support or have a higher likelihood of straining their social support networks
(Schulz & Williamson, 1991). This is potentially even more true of HIV-infected
individuals due to the social stigma, loss of employment networks, and social
isolation from family and peers often associated with the disease (Hays, Chauncy, &
Tobey, 1990). Thus, one might expect the magnitude of the relation between poorer
social support and increased medical nonadherence to be even greater for H IVpositive patients than for those with other, less stigmatized or disabling chronic
illnesses. Cohen's (1988; Cohen & Wills, 1985) three dimensions of social support,
which include emotional support [affection or compassion], informational support
[advice or new knowledge], and instrumental/tangible support [practical assistance in
the form of services or materials], have all been demonstrated to promote
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psychosocial adjustment among HIV-infected individuals (Hays, Turner,& Coates,
1992; Rabkin et al., 1990).

Instrumental support, in the form of assistance with

tangible everyday needs (e.g., transportation to medical appointments, medication
reminders) may be especially relevant to HIV-related treatment adherence due to the
impairments in daily functioning experienced by many patients. Also, emotional
support increases hope among HIV-positive individuals (Rabkin et al., 1990; Zich &
Temoshok, 1987), which may in turn promote treatment adherence.
Hopelessness.
The general adherence literature lacks investigations speciOcally examining
the role of hopelessness as a predictor of nonadherence among the chronically ill.
However, affective distress in general has been proposed to increase physical illness
by increasing the probability of poor health behaviors, including medical
nonadherence (Cohen & Rodriguez, 1995). For example, studies with hemodialysis
patients (Tracy, Green, & McCleary, 1987) and with cancer patients (Ayeres, Hoon,
Franzoni, Matheny, Cotanch, & Takayanagi, 1994) yield mixed results regarding the
hypothesized relationship between emotional distress and nonadherence. Increased
depression among hemodialysis patients has been related to increased dietary, fluid,
and medication nonadherence; whereas in an oncology setting, increased depression
and anxiety were associated with increased adherence to chemotherapy appointments
(Ayeres et al., 1994; Tracy et al., 1987). In sum, no clear relation between
depression and nonadherence has emerged from the chronic adherence literature and
the role of hopelessness within this context has not been specifically examined.
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In one of the few studies bridging the fields of HIV and medical adherence,
however, Blumenfield and colleagues (1990) suggested (but did not test) the
hypothesis that depression among AIDS patients results in hopelessness, which in
turn results in nonadherence in the form of giving up and refusing treatment
procedures. Conceptually, the role of hopelessness in predicting nonadherence can
be viewed within the context of the Health Beliefs Model (Becker et al., 1979). A
belief that the disease will improve with treatment is a central tenant of this medical
adherence model (Nagy & Wolf, 1984). Thus, loss of hope for the future is very
likely to be related to HTV-infected individuals' motivation to seek out and adhere to
medical treatment. In light of the earlier discussion of measurement issues
regarding an overlap of depressive and HIV symptoms, and the relative conceptual
and methodological importance of hopelessness as an index of distress among HIVinfected individuals (Kalichman, 1995; Rabkin et al., 1990), a direct empirical test of
the hopelessness-nonadherence relation appears warranted.
RçligiptM Coping,
A review of the adherence literature suggests that, with the possible exception
of avoidance coping or denial, general coping strategies have not been consistently
linked to adherence among chronically ill patients (Dunbar-Jacob et al, 1995;
Sherbourne et al., 1992). Strategies more specific to terminal illness, such as
religious coping, have not been adequately developed within the current body of
adherence knowledge. Likewise, although a number of studies have examined the
relations between religiosiQr and both psychological and physical health, none which
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included adherence were identifîed in a systematic review of this literature (Larson,
1993). Relevant research has documented the importance of religious coping in
ads^tation to life-threatening disease, however. Religiosi^ has been associated with
reduced distress, increased social support, and improved health outcomes among a
wide range of medical populations (Larson & Larson, 1994), For example, some
pertinent findings among outpatient, hospitalized or advanced stage oncology patients
include: (a) religious values are related to decreased anger, distress, and social
isolation and to increased life meaning (Acklin, Brown, & Mauger, 1983); (b)
religiosity is linked to decreased anxiety (Kaczorowski, 1989); (c) perceptions of God
as a source of external control are positively correlated with adjustment to cancer
(Jenkins & Pargament, 1988); and (d) increased religious activities may enhance
emotional well-being (Yates, Chalmer, St. James, Follansee, & McKegney, 1981).
For many medical patients, the difficulties of facing a life-threatening illness
are often met with an increased reliance on religious belief. A recent finding that
prayer is the single most frequently endorsed coping strategy used to deal with HIV
status among a heterogenous, low SES sample of infected outpatients supports this
contention (Jones et al., 1996). Similarly, Kalichman (199S) found that as many as
40% of HTV-infected individuals report finding new Aith, while more than 60%
frequently hope that a miracle will happen.

Religious practices and beliefs may

serve several important purposes for people with H IV infection. Beliefs in a higher
power and social support from a religious community may both be sources of
emotional support (Kalichman, 1995).

Spiritual coping may also serve to guide
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problem-solving (Folkman et al., 1992). Many anecdotal and case study
investigations have implied that increased importance o f religious beliefs and
behaviors in response to H IV may stem from a search for meaning (Carson, Soeken,
Shanty, & Terry, 1990; Kendall, Gloerson, Gray, McConnell, Turner, & West,
1989; Moynihan, Christ, & Silver, 1988). All terminal illnesses, but particularly a
stigmatized and unpredictable syndrome like HIV/AIDS, may raise spiritual questions
regarding the meanings of life and suffering, the nature of death, and how to come to
terms with feelings of punishment or lost control. Carson and colleagues (1990)
have also suggested that spiritual well-being is strongly linked to hope among
individuals living with AIDS.
The importance of religious coping among H IV populations is just beginning
to be researched. Thus far, the use of religious/spiritual behaviors and coping
strategies among HIV-infected individuals has been suggested by empirical studies to
have a role in immune functioning, psychological distress, and high risk sexual
behaviors (Folkman, Chesney, Pollack, & Phillips, 1992; Franks, Templer,
Cappelletty, & Kauffman, 1990; Somlai, Kelly, Kalichman, Mulry, Sikkema,
McAuliffe, Multhauf, & Davantes, 1996; Woods, Antoni, Ironson, & Kling, 1996).
A ground-breaking study by Woods and colleagues (1996) found that endorsement of
religious behaviors was associated with higher T-cell counts, whereas endorsement of
religious coping was significantly associated with less depressive and anxiety
symptomatology among 106 HIV-infected gay men. In a particularly strong
conceptual investigation of spirituality, coping and emotional distress among a
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heterogenous sample of 65 individuals with HIV or AIDS, religious beliefs and
practices were strongly associated with lower levels of depression, anxiety,
suicidality, and loneliness (Somlai et al., 1996). In an investigation conducted by
Folkman and colleagues (1992) in San Francisco, spiritual activities (i.e ., religious
service attendance, personal meditation, reading spiritual literature, consulting a
religious leader, and talking to others about spiritual concerns) were inversely related
to high-risk sexual behaviors among 398 gay and bisexual men. This is important
because the study demonstrated a link between religious behavior and health behavior
(Folkman et al., 1992). In sum, newly emerging research indicates that religious
coping is an important construct to address in future investigations of psychosocial
functioning and health-related behaviors among HIV-infected individuals.
Stage of illness.
As discussed earlier, high rates of medical nonadherence have been
documented among patients both early and late in the course of H IV infection
(Blumenfield et al., 1990; Fischl et al., 1990). The limited number of studies
examining adherence rates among H IV and AIDS patients have primarily looked at
adherence during one point along the disease continuum. To date, no known studies
have directly compared nonadherence rates across different phases of the HIV
disease spectrum.
Given that adherence is hypothesized to be related to social support, coping,
and distress among HIV-infected individuals, it should be noted that several studies
have explored variations in these psychosocial variables across disease status groups.
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One relevant study conducted by Pakenham, Dadds, and Terry (1994), yielded
ambiguous results regarding the relation of social support and coping across
symptomatic and asymptomatic HIV-positive individuals. The study did not include
AIDS patients in the comparison. The authors' interpretation was that relations
between coping strategies and psychosocial adjustment didn't vary across disease
stages, but that some components of social support (level of emotional support and
frequency of social contact) did vary across H IV phases. Also of interest, several
studies have yielded equivocal results regarding the relationship between distress
symptoms and immune markers for disease progression (Chuang et al., 1989; Kelly
et al, 1993; Perry et al., 1992). The majority of research in this area has examined
emotional distress during only a single point along the HIV/AIDS continuum, or has
not directly compared psychosocial functioning across the three major phases of
Illness.
Chronicitv of treatment.
One very consistent determinant of medical nonadherence is the length of
treatment (Dunbar-Jacob et ai., 1995). Nonadherence usually increases over time.
In general, the longer a treatment regimen must be adhered to, the less likely
adherence will be maintained (Agras, 1989; Richardson, 1986; Goodall & Halford,
1991). During the course of disease progression from H IV infection to AIDS,
patients must repeatedly return for medical care over time. Medical management of
the disease may entail a long series of treatment demands. Patients are expected to
have blood drawn regularly for the purpose of monitoring immune status. A number
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of medical contacts may be required to screen for or provide prophylaxis for various
opportunistic diseases (U.S. Department of Health and Human Services, 1994).
Many common HIV/AIDS-related pharmacological interventions (i.e ., antiretroviral
medications, PCP preventive agents) involve adherence to long term drug regimens.
Thus, it is highly likely that ctors such as the length of medical care may predict
6

treatment adherence among HIV-infected outpatients.
Consistencv of Care.
The importance of provider/patient relationships has been another long
established research finding. The quality of provider/patient interactions can affect
patients adherence to appointments as well as to other medical instructions (Sharbaro,
1990). Patient satisfaction with medical care and consequently, adherence, may be
influenced by u:tors identified in the early adherence literature such as physician
6

communication skills, warm interactional style, and willingness to address patient
concerns (Davis, 1978; Korsch & Negrete, 1972). Besch (1995), in a later review of
literature relevant to adherence in AIDS clinical drug trials, concluded that continuity
of care may be an important factor in increasing adherence. Consistent medical care
by a provider over time may be important because it provides opportunities for
patients to build trust in physicians and to ask questions.
Assessment of adherence to HIV/AIDS regimens.
Medical nonadherence may be measured in numerous ways (e.g., missed
medical appointments, procedures refused, pill counts, medication blood levels,
medical staff ratings, patient self-reports) (Dunbar-Jacob et al., 1995). Adherence
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measures that rely on self-report or indirectly monitored behaviors are problematic.
For example, the most nonadherent patients are least accurate in their self
descriptions of adherence (Mazur, 1981). In the context of an outpatient HIV clinic,
missed medical appointment are therefore likely to be a relatively more reliable
nonadherence measure. More importantly, a meaningful measure of nonadherence
across the HIV/AIDS disease spectrum must take into account the extensive
variabili^ in treatment regimens necessitated by the widely varying natural course of
infection. Attendance at medical t^pointments serves, in a sense, as a "common
denominator” o f adherence to diverse HIV-related treatment regimens (e.g.,
prophylactic, symptom alleviating, pharmacological, or lifestyle change
interventions).

In other words, every patient infected by H IV or diagnosed with

AIDS must first show up for appropriate medical care in order to receive or benefit
from it.
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PURPOSE OF THE STUDY
Given the importance of medical interventions in slowing disease progression
and improving quality of life among HIV-infected individuals, the present study
attempted to identify psychosocial and medical care factors predictive of
nonadherence to outpatient HIV treatment services. Based on pilot data indicating
36% of medical appointments in this population are not attended, nonadherence was
measured in terms o f outpatient HIV clinic attendance. Percentage of medical
appointment attendance appeared to be the measure of choice for comparisons across
the HTV/AIDS disease spectrum, since all patients must consistently seek medical
care in order to benefit from it. The primary purpose of the study was to identify
factors associated with patients not returning reliably for medical services.
Therefore, the constructs of social support, religious coping, and hopelessness were
explored among HIV-positive outpatients varying in length of treatment and disease
status in terms of their subsequent medical nonadherence (as monitored over an
approximately -month period of time). Specifically, the present study sought to
6

address three research questions.
First, do psychosocial Actors (hopelessness, religious coping behaviors,
perceived social support) and medical care factors (length of treatment, disease
status, physician consistency) predict percentage of medical appointment
nonadherence? It was hypothesized that psychosocial factors would add signiOcantly
to the variability in nonadherence accounted for by medical care Actors. Although
precise predictive tests of HIV-related nonadherence had not yet been conducted, a

32
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synthesis of nonadherence research with other chronic medical conditions (e.g.,
Agras, 1989) and the psychosocial H IV literature (e.g., Rabkin et al., 1990; Siegel
& Krauss, 1991; Somlai et al, in press) suggested these variables would be predictive
of nonadherence in HIV and AIDS patients. Specifically, it was hypothesized that
longer duration of medical care, less consistent care, and less adequate psychosocial
functioning (i.e ., high levels of hopelessness and low levels of social support and
religious coping) would be associated with greater nonadherence.

Given the lack of

empirical investigation of nonadherence to HIV-related treatment, the relative
predictive strength of these variables was unknown. Therefore, while the study
explored the unique contribution of each psychosocial and medical care variable in
the prediction of nonadherence, no hypothesis was advanced regarding which
variables would be the most powerful predictors.
Second, would outpatients vary in terms of psychosocial adjustment and
coping resources (hopelessness, religious coping, social support) across disease status
groups (HTV-infected, immunocompromised, AIDS)? Just as the medical demands
may be different across the diagnostic spectrum, emotional responses may also be
difierent for patients who are confronting the fact that the virus is taking its toll or
those who are hopeful it will be many years before they contract an AIDS-related
disease. Much of the existing literature has examined general coping, support, or
distress during a single point along the HIV/AIDS continuum or has not directly
compared the psychosocial functioning indices of primary interest in the present
study across the three major phases o f illness (Chuang et al., 1989; Kelly et al.
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1993; Pakenham et al., 1994; Perry et al., 1992). Thus, although prior research
suggested that psychosocial functioning changes across the H IV disease spectrum,
there was not a firm basis for specific directional hypotheses regarding differences in
hopelessness, religious coping, and social support at different stages of illness.
Third, would outpatients vary in medical nonadherence across disease status
groups (HIV-infected, immunocompromised, AIDS)? Subjects were categorized into
discrete groups to address this question because of the psychosocial and medical
implications associated with diagnostic status. The medical demands may be very
different for a patient who is asymptomatic, one who has already received an AIDS
diagnosis, or one who has just been prescribed AZT for the first time after their Tcell count drops below 500. Although no research to date had explored this question
directly, the hypothesis was based on the well-documented premise that patients at
different phases along the HIV-AIDS disease spectrum are asked to adhere to very
different treatment regimens (U.S. Department of Health and Human Services,
1994).
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METHOD
Subjççt$
Volunteers were recruited during their medical appointments at an ambulatory
care H IV clinic located at Earl K. Long Medical Center, a public hospital in Baton
Rouge. H IV seropositive outpatients were eligible to participate in the study if they
could read and were at least 18 years old. One-hundred-seventy-three (173) patients
agreed to participate. O f these participants 13 were ineligible (i.e., 1 was later
determined to be H IV seronegative and 12 were excluded due to incomplete or
invalid responses), resulting in an initial 160 participants whose outpatient
appointments were followed over time. One multivariate statistical outlier was later
excluded from the initial sample of 160, yielding an N of 159 participants who were
included in at least one of the study's main analyses. Demographics of all 159
participants are presented in Tables 1 and 2 below, whereas descriptive information
about subsets of the sample used in specific analyses are presented in the results
section.
Eight participants who expired within the 7-month study period were excluded
a priori from follow-up appointment attendance analyses.

One additional participant

was excluded, as he primarily used a private physician rather than the public hospital
clinic, yielding a final follow-up H of 150 for whom valid attendance and disease
status data were obtained. Only 144 participants both completed all study measures
and survived the study period.

Thus, the total number of participants included in

the analysis of primary interest was 144.
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The total sample was comprised of 57 African-American females (35.8%), 48
African-American males (30.2%), 39 Caucasian males (24.5%), 12 Caucasian
females (7.5% ), 2 Hispanic males (1.3% ), and 1 Hispanic female (0.6% ). Fifty-two
(32.7%) reported a history of injection drug use (IVDU) and 63 (39.4%) reported
sexual contact with injection-drug users as an infection risk factor. Fifty of the
participants had AIDS, 72 were in the immunocompromised range (CD 200-500),
4

and 36 of the participants were HIV-infected (CD > 500) [See Table 2]. O f the
4

8

subjects who expired prior to completing the study, 4 were African-American and 4
were Caucasian. Five of the deceased participants were male, 3 were female, 3 were
homosexual/bisexual, and

1

was a drug-injector.

Two-hundred-fifty outpatients were contacted for recruitment (i.e ., an
additional 77 patients were contacted who did not or could not participate in the
study). Thirty-nine of those contacted were ineligible; 37 had reading, visual,or
comprehension problems which prevented them from completing questionnaires,

1

did not speak English, and 1 was intoxicated. O f the patients who refused to
participate, 17 gave no reason, 16 declined due to time constraints, 2 declined due to
physical symptoms,

2

indicated they were concerned about confidentially, and

1

refused due to childcare responsibilities. Overall, 159 (63.6%) of the 250 patients
contacted were eligible volunteers, with 144 (90.5%) of them completing all aspects
of the study.
A consecutive patient sampling procedure was employed to maximize the
number of patients contacted for research participation. The H IV clinic from which
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participants were recruited provides medical services, health education, and social
services for HIV-infected outpatients. Letters confirming clinic appointment times
were routinely sent to patients, and transportation to the clinic was available through
an AIDS community service organization. The clinic is located at a public teaching
hospital serving a primarily low SES, medically uninsured population.
Materials
Nonadherence Measure.
Nonadherence was defined as the percentage of total medical appointments
no-showed during a 7-month period at the outpatient HIV clinic. Specifically,
nonadherence was measured by tallying the total frequency of appointments
scheduled (excluding those conflicting with hospital inpatient stays), tallying the
frequencies of appointments attended and missed, and then calculating the percentage
of total clinic visits recorded as missed due to no-shows. The data collection period
was 7 months to ensure that " -month” follow-up appointments were included in the
6

measure during times when clinic holiday closures caused scheduling conflicts.

In a

pilot study conducted by Catz, McClure, Jones, and Brantley (1995), two indices of
appointment nonadherence were calculated: (a) percentage of "no shows" for total
nurse and physician appointments scheduled, and (b) percentage of total appointments
missed (including both cancellations and no shows).

Although missed appointments

were operationalized in two ways to investigate whether including cancelled/
rescheduled appointments would improve the predictive ability o f the "no show"
measure, the results of the pilot study indicated that it did not do so (Catz et al..
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Table I. TOTAL SAMPLE DEMOGRAPHIC COMPOSITION
N

%

Gender
Male
Female

89
70

56.0
44.0

Race
Afncan-American
Caucasian
Hispanic

105
51
3

Orientation
Heterosexual
Caucasian
Minority
Male
Female
Homosexual/Bisexual
Caucasian
Minority
Male
Female
IVDU
Caucasian
Minority
Male
Female

1 1 1

2 1

90
42
69
48
30
18
47

6

6

. 0

32.1
01.9

69.8
13.2
56.6
26.4
43.4
30.2
18.9
11.3
29.6

1

0

52
13
39
32

32.7

2 0

8

. 6

. 2

24.5
2
1

0
2

. 1
. 6

IVDU Partner
Caucasian
Minority
Male
Female

51
26
37

39.4
7.5
32.1
16.4
23.3

Income
<$
$ $20-30,000

130
24
5

81.8
15.1
3.1

Deceased

8

5.0

1 0 , 0 0 0

1 0

2

0

, 0

0

0

63
1 2
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Table 2. DEMOGRAPHIC COMPOSITION BY DISEASE STATUS GROUPS
CD

4

<

2

0

0

CD 200-500 CD >500
4

4

N

%

N

%

Gender
Male
Female

33
17

20.9

39
33

24.7
20.9

2 0

Race
Caucasian
Minority

28

50

13.9
31.7

7
29

IVDU
Drug injector
Non-drug injector

16
34

21.5

24
48

15.2
30.4

24

7.6
15.2

Total Sample

50

31.6

72

45.6

36

2

M

SD

M

SD

M

sa

Age

33.3

7.51

34.18 7.99

34.13 9.56

Education

12.37 2.65

12.40 2.16

11.75 2.23

2 2

1 0 . 8

13.9
17.7

1 0 . 1

2 2

N

16

1 2

%

1 0 . 1

12.7

4.4
18.3

2

. 8
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1995). Therefore, the present study utilized only "no show" rates as the index of
medical appointment nonadherence. Percentage of appointments was used rather
than frequency to reduce the confounds inherent in variable numbers of appointments
being scheduled (e.g., due to patient health status, physician availability, and clinic
space limitations).
Psvchosocial Measures.
The Beck Hopelessness Scale (BHS) is a 20-item true-üüse scale for
measuring negative expectations about the immediate and long-range future (Beck,
Weisman, Lester, & Trexler, 1974; Beck & Steer, 1988). It has been used to assess
hopelessness and suicide risk in a variety of populations, including H IV samples
(Rabkin et al., 1990; Steer, Iguchi, & Platt, 1994). The scale has demonstrated high
internal consistency across clinical samples (KR-20 range = .82-.93) and adequate
test-retest reliability (.69). Concurrent validity of the BHS has been established with
comparisons to clinical ratings of hopelessness (.74) and the Beck Depression
Inventory pessimism item (.63). BHS scores range from 0 to 20, with higher scores
reflecting greater hopelessness.

Scores indicative of mild hopelessness range from 4

to 8. Cut-off scores of 9 indicate moderate hopelessness and scores of 14 or greater
represent severe hopelessness.
The Interpersonal Siq>port Evaluation List (ISEL) is a 40-item questionnaire
designed to measure perceptions of social support availability (Cohen, Mermelstein,
Kamarck, & Hoberman, 1985). Respondents rate each statement on a 4-point, truefalse scale indicating how accurately it describes their social support. Four domains
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of social support are tapped by the ISEL. Aggregate perceived social support scores
are generated by combining scores of four subscales (Appraisal, Belonging, Self
esteem, and Tangible). Higher ISEL scores are indicative of greater perceived social
support. The ISEL has demonstrated adequate construct validity as a predictor of
distress among HTV-infected outpatients (McClure, Catz, Prejean, Brantley, & Jones,
1996), as well as acceptable test-retest reliabili^ for aggregate scores in general (.87)
(Cohen, Mermelstein, Kamarck, & Hoberman, 1985).
The Ways c f Religious Coping Scale (WORCS) is a 40-item self-report
measure assessing the degree to which subjects engage in religious behaviors to cope
with stressful situations (Boudreaux, Catz, Ryan, Melendez, & Brantley, 1995).
WORCS items are rated on a 5-point Likert scale from not used at all' to used
always'. The behaviors included in the scale range from internally focused processes
such as prayer to externally focused processes such as participating in a church
support group. The WORCS yields a total score and two factor-analytically derived
subscale scores (Internal/Private and External/Social). The measure has been found
to be internally consistent (.95) and to have adequate concurrent and discriminant
validity as compared to measures of religious service attendance, ratings of the lifeimportance of religion, social desirability, and other religious coping questionnaires
(Boudreaux et al., 1995). The validity of the WORCS for use with general medical
patients and those with chronic illnesses including H IV has also recently been
demonstrated (Catz, Davis, Boudreaux, Brantley, & Howe, 1996; Davis, Catz,
Boudreaux, & Brantley, in press).
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Disease Status Measure.
H IV has the highest binding affini^ for T-helper lymphocytes with CD

4

surûice molecules (Fauci, 1988). Thus, H IV selectively destroys CD* cells. The
most conunon index of disease status among HIV-infected patients during the course
of the present study was therefore absolute CD* T cell counts (Kelly & St.
Lawrence, 1988). Current Center for Disease Control guidelines base
immunosuppression status (CD* < 500) and AIDS diagnosis (CD* < 200) on counts
of CD* cells per cubic milliliter of blood (CDC, 1992). Baseline CD* counts were
therefore monitored in the present study through medical chart review of routine
laboratory reports. Analyses of blood drawn at Earl K. Long Medical Center are
routinely conducted at the Medical Center of Louisiana, East Campus in New
Orleans. The procedures employed by this laboratory for obtaining CD* counts are
as follows. Absolute CD* counts are determined by mixing blood samples with
fluorescence tagged monoclonal antibodies, which are incubated with a dual-color
mixed cocktail of CD and CD* cells. Then, Coulter Q-Prep lysis is performed and
3

flow cytometry analysis is conducted. To measure CD*%, FS V Log SS signals are
then plotted and the lymphocyte region is gated for fluorescence analysis.

Finally,

absolute CD* counts (CD*/mm^) are calculated as the CD*% multiplied by the
absolute number of lymphocytes.
Procedure
Consecutive H IV seropositive outpatients were recruited during intake clinic
visits or physician visits. After giving informed consent [see Appendix], volunteers
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who met inclusion criteria were interviewed for demographic information (e.g., age,
race, gender, education, income, H IV notification date, transmission risk group) and
asked to complete a battery of psychosocial questionnaires. Baseline measures of
coping, hopelessness, and social support were collected in conjunction with an
ongoing research protocol. Patients were paid $5.00 for their research participation.
Following baseline data collection, nonadherence to medical appointments
was collected through review of clinic appointment records. All scheduled physician
and nurse visits at the HIV clinic were included. Frequencies of medical
appointments scheduled at the H IV clinic, cancellations, and "no shows” at
appointments were collected by the investigator. Prospective record review for the
7-month period of the study began with subjects’ date of entry into the study.
Blood was drawn and CD results were recorded in medical charts according
4

to routine outpatient clinic procedures. Disease status, length of treatment, changes
in attending physicians, and other relevant medical data were obtained through
review o f patient medical records by the investigator.
Design
The study followed participants' medical nonadherence prospectively over
time. The central focus of the study was a longitudinal analysis predicting future
nonadherence from baseline demographic, medical care, and psychosocial factors.
Subjects varied at baseline in terms of disease status and time lapsed since the onset
of H IV clinic services, so that the full range of disease and treatment chronicity
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could be sampled.
conducted.

Cross-sectional analyses at baseline and at 7 months were also

See Figure 1 for a schematic diagram of the research design.
{Regression Analysis}

Study Entry [---------------------------------------------------------------------------- ] 7 months
• Psychosocial Indices

• % Appointments No-showed

• niness Stage

• Physician Change Status

• Length of Treatment
(MANOVA: Psychosocial}

(ANOVA: Nonadherence}

Figure I. SCHEMATIC LAYOUT OF STUDY DESIGN
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RESULTS
Descriptive statistics were computed for all demographic, psychosocial, and
medical care variables to describe the characteristics o f the sample and to screen for
outliers. One outlier (> 3 SD) was excluded from the sample, as she appeared to be
an unreliable respondent on several measures. The demographic composition for the
portions of the sample who survived to complete the study and were included in the
ANOVA and the regression analyses are presented in Tables 3 and 4. Of the 150
subjects whose appointments attendance was tracked and compared cross-sectionally
by disease status groups, 83 (55.3%) were males and 67 (44.7%) were females. Onehundred (66.7%) were African-American, 47 (31.3%) were Caucasian, and 3 (2.0%)
were Hispanic. Approximately one third (34%) reported a history of injection drug
use and 40.7% reported contact with an injection drug using sexual partner. Less
than one third of the sample (30%) reported homosexual/bisexual orientation as a
transmission risk. There was substantial overlap between transmission risk groups
and gender/racial groups (see Table 3). A majority of subjects (83.3%) reported
annual incomes below $10,000 with only 5 (3.3%) individuals earning more than
$

2 0

, 0

0

0

yearly.

Of the 144 subjects who were included in the longitudinal analysis predicting
adherence from baseline information, 55 (38.2%) were African-American females,
40 (27.8%) were African-American males, 35 (24.3%) were Caucasian males, 11
(7.6%) were Caucasian females, 2 (1.4%) were Hispanic males, and only 1 (0.7%)
was a Hispanic female. As the number of Hispanic participants was too small for

45

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

46
Table 3. DEMOGRAPHIC COMPOSITION FOR ANOVA ANALYSIS
N

%

Gender
Male
Female

83
67

55.3
44.7

Race
African-American
Caucasian
Hispanic

47
3

Orientation
Heterosexual
Caucasian
Minority
Male
Female
Homosexual/Bisexual
Caucasian
Minority
Male
Female

1 0 0

105
19
8 6

39
6 6

45
28
17
44
1

IVDU
Caucasian
Minority
Male
Female

51

IVDU Partner
Caucasian
Minority
Male
Female

61

Income
<$
$ $20-30,000
1

1 0

0

2

, 0

0

, 0

0 0

0

0

1 2

39
31
2 0

1 1

50
24
37

125
2 0

5

66.7
31.3
0

2

. 0

70.0
12.7
57.3
26.0
44.0
30.0
18.7
11.3
29.3
0.7
34.0
8

. 0

26.0
20.7
13.3
40.7
7.3
33.3
16.0
24.7

83.3
13.3
3.3

N = 150
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Table 4. DEMOGRAPHIC COMPOSITION FOR REGRESSION ANALYSIS
N

%

Gender
Male
Female

77
67

53.5
46.5

Race
African-American
Caucasian
Hispanic

95
46
3

Orientation
Heterosexual
Caucasian
Minority
Male
Female
Homosexual/Bisexual
Caucasian
Minority
Male
Female
IVDU
Caucasian
Minority
Male
Female
IVDU Partner
Caucasian
Minority
Male
Female
Income
<$
$ $20-30,000
1 0 , 0 0 0

1 0

2

0

, 0

0 0

1 0 1

19
82
35
6 6

43
27
16
42
1

48
1 2

36
27
2 1

60
1 1

49
2 2

38

1 2 0

2

0

4

6

6

. 0

31.9
0

2

. 1

70.1
13.2
56.9
24.3
45.8
29.9
18.8
ll.l
29.2
0.7
33.3
8.3
25.0
18.8
14.6
41.7
7.6
34.0
15.3
26.4

83.3
13.9
2

. 8

N = 144
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comparison purposes, they were included as part of a "minority” group in the
regression analysis. As subjects were predominantly low income (83.3% <
$10,000; 13.9% = $10-20,000; 2.8% > $20,000 annually), the meaningfulness of
comparisons between economic groups in this sample was extremely limited.
Transmission risk groups tended to vary in terms o f their ethnic and gender makeup.
For example, in this public hospital sample, those with a homosexual/bisexual risk
factor were more likely to be Caucasian, while injection drug users were more likely
to be minorities, and those reporting IV drug using partners were more likely to be
women or ethnic minorities (see Table 4).
Descriptive statistics for the factors investigated in the regression analysis are
presented in Table 5. Education levels ranged from primary school (4th grade) to
graduate school (19 years), with a mean 12th grade education. Mean subject age
was 33.76, with the oldest subject aged 58. Immune status varied widely, with
absolute CD counts ranging from 2 (i.e., end stage AIDS) to 1310 (i.e., normal
4

immune functioning). The mean length of treatment at study entry for subjects
completing the study was t^proximately one year, with treatment duration ranging
from initial contact

( 0

months) to more than 4 years (51 months). Scale norms

indicated that mean Beck Hopelessness Scale scores (M = 5.53) fell within the "mild
hopelessness" range (Beck & Steer, 1988). Perceived social support as measured by
the ISEL (M = 117.3) was higher in this sample with widely varying disease
severity and treatment length, when compared to a mean of 81.5 found in an earlier
study sampling only patients at their first appointments in the same clinic (McClure
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et al., 1996). Surprisingly, religious coping scores (M = 91.6) were lower than in
primary care and hemodialysis samples with which the WORCS has been employed
(Davis et al., in press). Thus, participants surviving the study were characterized by
mild hopelessness and relatively positive perceptions of social support, as well as
relatively little use of religious coping strategies.
An exploratory correlation matrix was computed to examine continuous
demographic variables (e.g., age, education, seropositive notifîcation time) and
interrelations among all experimental variables (see Table ). Age was positively
6

correlated with education and length of diagnosis, and was negatively correlated with
no-show percentage rates. Hopelessness was strongly and inversely related to social
support and religious coping, and was weakly associated with percent appointments
no-showed in the expected positive direction. Although social support was
moderately related to no-show rates in the hypothesized negative direction, it should
be noted that social support levels (but not no-shows) were also significantly
correlated with greater education. The correlation ^ = .42) between duration of
treatment and months since HIV diagnosis suggests that the treatment length variable
employed in this study somewhat reflects illness duration as well as treatment
duration. Also of interest, percent appointments no-showed were weakly and
positively related to CD* counts, but were not significantly associated with education,
months since diagnosis, months of treatment, or coping.
For the categorical variables (e.g., gender, orientation, race, injection drug
use, income), descriptive frequency and mean comparison analyses were also
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Table 5. DEMOGRAPHIC AND DESCRIPTIVE STATISTICS FOR STUDY
COMPLETERS

Education
Age
Months of Treatment
CD
BHS
ISEL
WORCS
4

Mean

SD

Range

12.26
33.76
12.33
350.7
5.53
117.31
91.62

2.31
8.14
14.31
269.09
4.77
23.18
35.71

4-19
18-58
0-51
2-1310
0

- 2

0

59-159
10-160

N = 144
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Table . CORRELATION MATRIX OF DEMOGRAPHIC, INDEPENDENT AND
DEPENDENT VARIABLES
6

1

1.
2.
3.
4.
5.
.
7.
.
9.
6

8

.

2

.

Age
.23"
Education
—
Months H IV +
% No Showed
BHS
ISEL
WORCS
Months Treatment
CD

3.

4.

5.

. " -. "
.16' -.15
2

—

2

2

. 0

—

1

2

6

- . 0

1

- . 0

2

.03
.16'
—

.

.06
.2T*
.09
-.29*"
-.47"*

7.
. 1 1

-.04
.06
.13
-.36***
.08
—

8

9.

.
.06

- . 0

0

. 0

2

- . 1

2

.42*" -.19*
-.05
.18*
-.04 -.15
.09
.05
. 1

——

4

*U < .05
< .01
* * * £ < .001
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0
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conducted for all experimental variables across demographic groups (see Tables 710). Substantial overlap was noted among demographic groups (e.g., Caucasians and
men; %%e and education) and power limitations precluded examining more than two
additional factors in the nonadherence model. Therefore, age and race were selected
as relevant demographic variables to be controlled in the hierarchical regression
model on the basis of their relatively strong relations to nonadherence in the
descriptive analyses. Results indicated that minorities had significantly higher rates
of nonadherence as compared to Caucasians ( i (148) = 4.14, g < .(X)l) and that
younger age was significantly associated with greater nonadherence (r — -21,
g < .01). No significant associations or group di^erences in nonadherence were
found for education, income, gender, sexual orientation, or injection drug use
history.
DiAerences between participants who survived the study and those who died
(n = ) during the 7-month course of the study were examined. Deceased patients
8

had more education (M = 14.6,1 (157) = 2.79, g < .01) and they were more
hopeless (M =

1 0

. , t (157) = 2.42, g < .05) than participants in general.
0

However, the hopelessness of deceased patients was not signifîcantly different in
comparison to other AIDS (C D *< 2CX)) patients who survived to be included in the
adherence analyses. Deceased patients did not differ significantly from all survivors
in terms of age, social support, coping, or treatment length.
It should be noted that of those who survived for 7 months after entry into
the study, 5 patients had died by month , 1 by month 9, and 3 were known to have
8
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died by month 12 after study entry. Thus, patients very near the end of their lives
were included in the adherence analyses despite the necessary exclusion of patients
who expired before the end of the appointment follow-up period. Additionally, the 3
participants identified as receiving hospice care during a portion of the 7-month study
period did not differ significantly in nonattendance rates from other participants, and
so were retained in subsequent analyses.
Proportional data (i.e., percentage of appointments no-showed) by the nature
of how it is derived, may not be normally distributed. Inspection of residual
scatterplots suggested that the distribution o f nonadherence data was negatively
skewed, so an appropriate transformation (i.e ., arsine) of this percentage variable
was performed to normalize the distribution prior to conducting further analyses
(Cohen & Cohen, 1983). For ease of interpretation, the raw appointment data are
presented in tabular form (Table 11). Across all subjects surviving the study period,
an average of

6

. 6

outpatient HIV clinic appointments were scheduled, with the

frequency of scheduled ^pointments ranging from 2 to 23 during a 7-month period .
Both the frequency of appointments missed due to no-shows alone and missed due to
no-shows plus cancellations ranged from

0

to , with means below
8

2

appointments.

Approximately one fourth of scheduled appointments were no-showed (25.5%), with
appointments missed due to cancellation/rescheduling about 4% higher (29.4%).
To test the primary research question, a multiple regression analysis was
performed using a hierarchical regression of sets procedure (Cohen & Cohen, 1983)
in which medical care variables were entered as a simultaneous block subsequent to
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Table 7. MEAN NONADHERENCE BY DEMOGRAPHIC GROUPS
Percent Appointments No-Showed
M

SD

Gender
Male
Female

24
28

20
22

Race
Caucasian
Minority

15***
30«.

19
21

Orientation
Heterosexual
Homosexual/ Bisexual

28
21

21
19

IVDU
Drug Injector
Non-Drug Injector

30
23

20
21

Income
<$10,000
$10-20,000
$20-30,000

27
22
10

21
19
15

*p < .05
< .01
< .001
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Table 8. PSYCHOSOCIAL MEANS BY DEMOGRAPHIC GROUPS
ISEL

BHS
M

WORCS

m

M

m

SD

M

Gender
Male
Female

5.71

5.25
4.71

118.8
116.5

25.03 86.79
21.54 94.38

38.03
33.74

Race
Caucasian
Minority

6.56
5.55

5.18
4.92

123.4*
115.1*

22.81 69.72***
. ***
23.40

37.79
31.19

Orientation
Heterosexual
Homo/ Bisexual

5.10

5.24
4.40

114.T
124.7*

23.73 96.35**
21.49 75.74**

34.37
36.83

95.02
23.76 87.84

34.37
37.07

23.68 91.42
20.94 87.13
11.96 73.00

35.43
34.39
64.42

6 . 0 1

6 . 2 2

IVDU
Drug Injector
7.17*
Non-Drug Injector 5.25*

5.34
4.74

Income
<$
$ $20-30,000

4.99
5.55
2.83

1 0

1 0

2

, 0

0

, 0

0 0

0

0

5.90
5.96
5.00

. **
121.3**
1 1 0

2

115.7*
129.1*
117.5

1 0 0

2

1

. 1

0

0

< .05
< .01
< .001
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Table 9. MEDICAL GARE MEANS BY DEMOGRAPHIC GROUPS

CD4

Months Treatment

M

m

M

SD

Gender
Male
Female

298.39*
392.41*

236.28
296.91

10.56
14.50

13.04
15.79

Race
Caucasian
Minority

257.82**
379.23**

200.14
287.68

13.04
11.96

15.02
14.17

Orientation
Heterosexual
Homosexual/ Bisexual

349.76
317.77

272.05
260.24

13.23
1 0 . 2 1

14.95
12.99

IVDU
Drug Injector
Non-Drug Injector

337.08
341.50

227.17
287.05

13.71
11.62

14.14
14.56

Income
<$
$ $20-30,000

353.62
284.42
256.80

275.35
233.15
221.55

12.50
10.63
15.40

14.30
15.86
14.41

1 0 , 0 0 0

1 0

2

0

, 0

0

0

< .05
< *01
< .001
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Table 10. PHYSICIAN CHANGE BY DEMOGRAPHIC GROUP FREQUENCIES
Physician Changed

Physician Same

H

N

ChF

71
62

1 . 8

Gender
Male
Female

5

Race
Caucasian
Minority

9

Orientation
Heterosexual
Homosexual/ Bisexual

7

1 2

IVDU
Drug Injector
Non-Drug Injector
Partner
Drug Injector
Non-Drug Injector
Income
<$
$ $20-30,000
1

1 0

0

2

, 0

0

, 0

0 0

0

0

8

1 0

7
1 0

4
13

13
3
1

39
94

2

. 2

95
38

1 . 1

44
89

0.4

57
76

2.3

1 1 2

17
4

< .05
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the entry of demographic Actors and prior to the entry of the set of psychosocial
variables. Age and race were selected as demographic variables to be controlled in
the regression model on the basis of their relations to nonadherence in the descriptive
analyses. In this analysis, race was dummy coded as Caucasian versus minority and
medical provider consistency was dummy coded as either doctor changed or not
changed during the course of the study. The overall hierarchical regression model
supported the hypothesis that psychosocial factors (hopelessness, religious coping
behaviors, perceived social support) added significantly to the variabiliQr in medical
appointment nonadherence accounted for by medical care Actors (length of
treatment, disease sAtus, physician change), when relevant demogrt^hic factors (age,
race) were controlled for in the first block (R^ = .24, F ( I, 143) = 5.29, p <
.(X)I). Specifcally, age, race, disease sAtus, and perceived social support were
significantly assocAted with the percent of medical appointmenA no-showed [See
Table 12]. In block 1, greater nonadherence was associated with younger age
(P = -.20, t — 2.66, p < .01) and minority sAtus (t = 2.22, p < .05). In block 2,
higher t-cell counA (i.e ., healthier disease sAtus) were associated with greater
nonadherence (P = .16, t = 2.15, p < .05), but the other medical care Actors did
not contribute independently to the prediction of nonadherence. In block 3, social
support was the only significant psychosocial predictor of nonadherence, with higher
levels of perceived social support associated with lower rates of nonadherence
(P = -.19,1 = 2.17, p < .05).
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To test the second research question, a MANOVA comparing hopelessness,
social support, and coping at baseline across disease status groups was conducted.
The multivariate analysis yielded no significant difference in psychosocial measures
as a function of disease group. Mean hopelessness, social support, and coping scores
for each disease status group (AIDS, immunocompromised, and HIV-infected) are
presented in Table 13.
A One-way ANOVA was performed to examine the third research question
regarding whether appointment nonadherence rates would vary across disease groups.
Significant difierences in nonadherence at follow-up were found across disease status
groups, (F (2, 147) = 3.19, p < .05). Tukey HSD post-hoc comparisons indicated
that the least ill HIV-infected patients had significantly greater percentage rates of
appointment no-shows than immunocompromised patients, but were not significantly
difiërent from the nonadherence rates of AIDS patients. AIDS patients also did not
significantly differ fiom those in the immunocompromised range. Mean percent
nonadherence across disease groups is presented in Table 14. Interestingly,
examination of the percentage data within the context of the appointment frequencies
presented in Table 15, suggests that these findings are not merely an artifact of
differing schedule demands across disease groups providing variable opportunities to
miss appointments.
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Table 11. APPOINTMENT NONADHERENCE FOR ALL SURVIVORS

Frequency Appointments No-Showed
Frequency Appointments Missed
Percent Appointments No-showed
Percent Appointments Missed
Total Appointments Scheduled

M

m

1.64
1.93
25.5
29.4

1.61

0

- 8

1

0

- 8

2

1

. 1

2

1

. 2

6

3.44

. 6

Range

. 6 6
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0-78
0-80
2-23
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Table 12. HIERARCHICAL MULTIPLE REGRESSION PREDICTING
PERCENTAGE OF NO-SHOWED APPOINTMENTS
Block Variable
1

2

3

Multiple R

Age**
.37
Race*
CD4*
Treat Length
MD Change .39
BHS
WORCS
ISEL*
.49

R

F

.14

11.35***

.15

5.01***

. 0 1

.24

5.29***

.09**

2

R^ Change

< .05
N = 144
* * U < .01
< .001
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Table 13. PSYCHOSOCIAL MEASURES BY DISEASE STATUS GROUPS
CD 200-500

CD >500

Mean SD

Mean SD

Mean SD

7.32 5.46
113.5 25.09
81.80 41.93

5.22 4.80
118.5 23.45
96.52 29.93

5.25 4.48 158
121.6 20.13 151
89.51 38.27 156

CD

BHS
ISEL
WORCS

4

<

2

0

0

4

4
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Table 14. MEAN PERCENT APPOINTMENT NONADHERENCE BY DISEASE
STATUS GROUPS
CD

CD* 200-500

CD* >500

Mean SD

Mean SD

Mean SD

25.25 20.94

2

4

% No-Showed

<

2

0

0

2

.

1 0

* 20.06

32.75* 21.99

•'group differences, g <.05
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Table 15. MEAN FREQUENCY APPOINTMENTS BY DISEASE STATUS
GROUPS
CD

CD 200-500

CD >500

Mean SD

Mean SD

Mean SD

8.33
2.02

5.94
1.31

5.72

4

Total Scheduled
Total No-Showed

<

2

0

0

4.60
1.96

4

2.73
1.31

4

1

. 8
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6

2.28
1.60

DISCUSSION
The primary aim of this study was to identify factors predictive of
nonadherence to outpatient HIV treatment services. Results indicated that age, race,
disease severity, and perceived social support predicted no-shows at H IV clinic
appointments. Specifically, greater nonadherence to outpatient appointments was
associated with younger age, minority background, less severe illness, and lower
perceived social support. Although demographic characteristics (age, in particular)
predicted the greatest variance in appointment nonadherence, the hypothesis that
psychosocial factors (hopelessness, religious coping behaviors, perceived social
support) and medical care factors (length of treatment, disease status, physician
consistency) would predict percentage of medical appointment nonadherence, was
supported even when the most relevant demographic predictors were first statistically
controlled. Additionally, it was hypothesized that psychosocial Actors would add
significantly to the variability in nonadherence accounted for by medical care factors.
This hypothesis was supported by the finding that psychosocial predictors as a block
contributed about 9% of the variance in nonadherence, after the medical care factors
had been entered as a block. As a group, medical care factors accounted for less
than 2% of the variability in nonadherence. Only CD* counts were a significant
medical care predictor in this model. O f the psychosocial factors, only social
support was significantly associated with nonadherence. Hypotheses that longer
duration of medical care, less consistent care, higher levels of hopelessness and
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lower levels of religious coping would be associated with greater nonadherence were
not supported.
Adherence to increasingly effective medical interventions designed to slow
disease progression is critical for improving the quantity and quality of life of
individuals infected with HIV. This study was based on the premise that all patients
must return consistently for medical services in order to benefit from any
HIV-related prophylactic or therapeutic interventions. Thus, percentage of medical
appointment nonattendance was conceptualized as a measure of nonadherence which
is both direct and versatile enough to make comparisons across the HIV/AIDS
disease spectrum. Overall, participants were found to attend on average about 70%
of H IV outpatient appointments (excluding those missed due to inpatient care).
Averaging across the disease spectrum, approximately one of every four
appointments was a "no-show." That is, about 25% of scheduled appointments were
neither attended or cancelled in this sample in which patients in the
immunocompromised range were over represented.
Patients at different phases along the HIV-AIDS disease spectrum are asked to
adhere to very different treatment regimens. Medical demands vary widely for
patients who are asymptomatic or those whose treatments must combat a host of
opportunistic AIDS-related infections. Results indicated that nonadherence, as
measured by no-show rates, varied according to disease status. Outpatients who
were not yet in the immunocompromised range (i.e ., those most likely to present
with mild to no symptoms) had significantly more nonadherent appointment keeping
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behavior than HIV-infected patients who were immunocompromised (i.e., those who
were likely symptomatic, but had not progressed to AIDS).

HIV-infected

outpatients with CD4 counts above 5(X) no-showed on average about one-third of
scheduled appointments, whereas immtmocompromised patients with CD4 counts
between 200 and 500 missed less than one in four (22%) of appointments due to noshows. Interestingly, nonadherence among the less ill HTV-infected patients was not
significantly different from sicker patients in the AIDS stage of the disease, who
were not adherent to appointments approximately 25% of the time. Further
investigation is needed to determine the reliability of this pattern and whether such
differences in appointment attendance have a significant clinical impact. The present
study is one of several recent studies to clearly demonstrate differences in
nonadherence across H IV disease severity (Singh et al., 1996), and one of the first to
find such differences in HIV outpatient appointment-keeping. In a recently published
pilot study conducted with 46 veterans with H IV or AIDS, Singh and colleagues
(1996) similarly demonstrated that a history of opportunistic infection prior to entry
into a prospective study was related to lower rates of medication nonadherence, as
measured by pharmacy records and laboratory test correlates associated with AZT
consumption. However, in their sample, no baseline differences in CD^ counts were
found across dichotomous AZT adherence/nonadherence groups.
Nonadherence rates in this cross-sectional portion of the study essentially
followed the same pattern that psychological distress is widely believed to follow
(Kalichman, 1995). That is, nonadherence was most pronounced early in the disease
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course, least problematic in the middle of the disease course, and then somewhat
higher (although not significantly so) when the disease progressed to AIDS.
However, cross-sectional baseline multivariate analyses did not support this
hypothesized pattern for the psychosocial measures employed in the present study.
Taken as a group, no significant differences in hopelessness, perceived social
support, and religious coping were found across disease status groups. One possible
reason for this finding might be related to the differing demographic makeup of the
disease status groups. For example, reflecting changing trends in HIV infection
patterns, the AIDS patients in this sample were more likely than more recently
infected individuals to be non-drug injecting, homosexual, Caucasian males. As
significant differences in the psychosocial measures were found across racial,
orientation, and drug injection groups, it may be that cultural and environmental
factors played a more important role in psychological adjustment to the disease than
did the stage of the disease itself.
The finding that younger age is associated with increased medical
nonadherence is consistent with work in progress in San Francisco (M . Chesney,
personal communication, March 9, 1997). Some possible explanations for this
phenomenon might include lack of previous medical contact or perceived
invulnerability to death among young adults, or differences in lifestyle fiictors such as
drug use or regularity of daily schedules. Results of the present study suggesting
that individuals from minority backgrounds and those early in the disease process are
at high risk for nonadherence are also consistent with other recent investigations
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(McClure, 1996; Muma et al., 1995; Singh et al., 1996). For example, in addition
to linking disease history to AZT adherence, Singh and colleagues (1996) found that
African-Americans in their sample had higher rates of nonadherence, independent of
other demographic factors such as education level or injection drug use.
Psychosocial adjustment was conceptualized in this study as comprised of
both the absence of distress (e.g., hopelessness) and adequate resources for managing
disease-related demands (e.g., coping and social support). Earlier H IV research
suggesting that social support plays an important role in medical nonadherence (e.g.,
Morse et al., 1991; Shelton et al., 1993) appears to be supported by the present
study. Higher levels of perceived social support were associated with less outpatient
visit nonadherence. Thus, there seems to be support for the idea that some
dimensions of adequate psychosocial adjustment may be negatively linked to
nonadherence. However, recent studies provide equivocal support for baseline levels
of distress predicting subsequent nonadherence to appointments or medication
regimens (McClure, 1996; Singh e ta l., 1996). Baseline levels of hopelessness and
religious coping were not found to be significant predictors of nonattendance in the
present study, just as depression and anxieQr were not supported as important factors
in McClure's (1996) investigation, despite the consistent finding that social support
has been linked to outpatient nonadherence. So, perhaps it the unitary dimension of
social support rather than a multi-component "adjustment” construct that is important
for promoting adherence.
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These psychosocial fîndings should be viewed within the context of the
limitations of the study. Rather than employing a repeated measures design, baseline
psychosocial data was utilized for the purpose of predicting subsequent nonattendance
outcomes, as missing data from those who never returned for bloodwork or
additional psychosocial batteries was thought likely to exclude from representation
the very research participants of most interest in the prediction model.
Unfortunately, this makes it difRcult to draw Orm conclusions about the importance
of constructs such as hopelessness, which are based here only on a cross-sectional
"snapshot” measure of this variable likely to fluctuate over time. Likewise, a good
deal o f the unaccounted for error in the medical care portion of the model may be
due to measurement issues. For example, consistency of care (i.e., change in
physician) is a Airly rough index o f the complex construct of patient/provider
relationships. Although it appeared important to include potential sources of
variability such as mid-study changes in providers, the way in which this variable
was measured in the present study did not tap into dimensions such as patient
satisfaction with the initial provider. Although additional subjects were recruited so
that adequate statistical power for the analysis could be retained when demographic
variables were included in the regression model, power considerations still limited
the number of predictor variables which could be investigated in this one study.
Much of the variance in nonadherence remained unaccounted for by the present
model. Thus, studies extending this line of research should focus on identifying
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additional factors predictive of HIV-related outpatient nonadherence, such as patient
satisAction with care or trait variables such as health locus of control.
Research in the area o f H IV nonadherence is at an early stage of theory
development, and the present study should be viewed as just one attempt to elucidate
possible Actors for future inclusion in a broad model of HIV-related nonadherence.
Management of H IV is a r^ id ly changing area, and new medical developments must
constantly be incorporated into the psychosocial research in this field. Just as data
collection was being completed for the present study, a new class of medications
called protease inhibitors were approved by the FDA. Combination medication
therapies including protease inhibitors have quickly become the standard of care
because such interventions have been demonstrated to dramatically reduce the rate of
viral reproduction, even to the point that viral load in the blood may be undetectable
and immunological decline is slowed or temporarily reversed (Fauci, 1996;
Marchland et al., 1996). Unfortunately, the newest treatment regimens are
extremely complex and difficult to tolerate. For example, nausea may be
pronounced when therapy is initiated, and the regimens require strict adherence to
taking multiple medications at frequent dose intervals carefully coordinated with
meals. Not only do these regimens require a lifestyle level of behavioral change to
be efficacious, but poor adherence leads quickly to the development of drug resistant
strains of HIV. As cross-resistance occurs across the class of protease inhibitor
drugs, a nonadherent patient could effectively cut him/herself off from the best
medical means of slowing disease progression by failing to take these medications as
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prescribed. Nonadherence to HIV-related treatments have thus taken on a new level
of importance in the past year. In the context of outpatient appointment
nonadherence, those who do not attend appointments regularly enough to receive the
best available medical care now are unlikely to benefit from the improvements in
quality and length of life which these treatments offer. From a public health
standpoint, it may also be critical to identify whether predictors of nonadherence to
combination medication regimens are the same Actors involved in nonadherence to
safer sexual and drug injection behavioral changes. It is conceivable that the very
individuals likely to develop resistant strains o f the virus due to nonadherence will be
the same individuals infecting others at the highest rates.
Clearly, future research must focus on identifying individuals most at risk for
nonadherence. The fîeld will also need to draw upon the general noncompliance
literature to develop interventions to promote adherence as rapidly as possible.
There are a number of other unanswered questions about adherence raised by these
newest medical advances. For example, w ill the complexity of the regimens
overshadow the importance of psychosocial influences on nonadherence, or w ill the
increasing difficulty of medical demands make tangible and informational types of
social support (i.e ., reminders to take medication; understanding of instructions),
self-efficacy (i.e ., belief in one's ability to carry out the necessary health behaviors),
or learning history (i.e ., time management behaviors; past medical care
reinforcement contingencies) become much more important factors in promoting
adherence? The current investigation of outpatient nonadherence, while not designed
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to address these emerging questions, does at least provide some clues about the type
of variables which should be included in future exploration of medication
nonadherence. The results o f this study suggest that a special focus on investigating
nonadherence among younger patients, those from minority backgrounds, individuals
with mild or no physical symptoms, and those reporting limited social support
resources may be warranted.
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SUMMARY
In summary, nonadherence to medical regimens has become a critical
behavioral threat to the health of HIV-infected individuals. Patients cannot benefit
optimally from increasingly efRcacious treatments for HIV/AIDs if they do not
adhere to their recommended regimens. Medical management of this chronic, lifethreatening syndrome entails regular medical monitoring and ongoing preventive and
curative interventions. Consistent medical care plays a key role in prolonging life,
improving general health, and enhancing overall quali^ of life among individuals at
each phase of the HTV/AIDS spectrum. Nonadherence to HIV-related medical
regimens therefore presents a very serious health issue (Chesney & Folkman, 1994).
At the time the present study was undertaken, few empirical studies had investigated
the magnitude of this problem or carefully explored biopsychosocial factors likely to
contribute to medical nonadherence in this population. Thus, this study attempted to
identify factors predictive of HIV-related outpatient nonadherence. Only by
developing a broad etiological model of HIV nonadherence are specific interventions
promoting improved adherence likely to be effective.
Percentage of medical appointment nonattendance was conceptualized as a
measure of nonadherence which was both direct and comprehensive enough to make
comparisons across the disease spectrum and diverse treatments regimens.
Nonadherence was demonstrated to be most pronounced early in the disease course,
least problematic in the middle of the disease course, and then somewhat higher
when the disease progressed to AIDS. Demographic, medical care, and psychosocial
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factors were identified that prospectiveiy predicted percentage of scheduled HIVrelated appointments no-showed by outpatients. Specifically, greater nonadherence to
outpatient appointments was associated with younger age, minority background, less
severe illness, and lower perceived social support. Individuals from minority
backgrounds and younger cohorts are at high risk for nonadherence

H IV treatment

demands. Those early in the disease process may also be at some risk for higher
rates of nonadherence. Particularly important from an intervention standpoint,
higher levels of perceived social support were clearly associated with less outpatient
visit nonadherence. This study represents an attempt to begin building a predictive
model upon which a more comprehensive theory of H IV nonadherence can grow.
Hopefully, future models will lead to effective interventions addressing current
barriers to H IV medication adherence.
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APPENDIX
INFORMED CONSENT
LOUISIANA STATE UNIVERSITY M EDICAL CENTER IN NEW ORLEANS
CONSENT FORM
1. Study Title: The impact of stress, mood, and social support on HIV
disease status.
2. Perlbnnamce Site: Early Intervention Clinic at Earl K. Long Medical Center,
Baton Rouge, Louisiana.
3. Names and Telephone Numbers of investigators:
For 24-hour access, please call:

(504)358-1105

PhUlip J. BranUey, Ph.D.

(504)358-1105

Glenn N. Jones, Ph.D.

(504)358-1429

Jennifer B. McClure

(504)358-1105

Sheryl L. Catz

(504)358-3927

4. Purpose of the Study: This is a research study designed to investigate how
stress, mood, social support, and general ways of coping impact the health status of
patients with H IV. Aside from participating in a brief psychological/medical history
and filling out questionnaires (e.g. on stress, H IV symptoms, mood, social support,
and coping) approximately every three to six months, research subjects w ill not be
treated any differently than other patients at the clinic. The laboratory analysis of
immune functioning is part of the medical assessment that all patients undergo
routinely.
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5. Subject Inclusion Criteria: Individuals between the ages of 18 and 65 are
eligible to participate in the study. Participants must be H IV positive.
6. Subject Exclusion Criteria: Individuals w ill not be eligible to participate in the
study if they are unable to read or comprehend the nature of the questionnaires for
any reason (e.g., illiteracy).
7. Description of the Study: During a routine clinic appointment, when laboratory
analysis of immune functioning has been scheduled, patients at the clinics will be
informed o f the study by a attending nurse or physician. If a patient volunteers to
participate, he/she will sign the informed consent. A graduate student in clinical
psychology at Louisiana State Universi^ will conduct an interview to gather a brief
medical and psychological history. Subject then w ill complete questionnaires (e.g.
on stressful life events, social support, mood, coping, and H IV symptoms). Subjects
allow the experimenter access to their medical records to obtain laboratory reports
and other medical information (e.g., medication usage, onset of symptoms, number
of visits to the clinic). At or before regularly scheduled follow-up clinic
appointments, participants will be reminded of the project and again asked to
complete the questionnaires.
8. Benefits to Subject: Subjects will receive $5.00 following each participation in
the study. Other potential benefits may include increased knowledge about H IV and
strategies to cope with the disease.
9. Risks to Subject: There are no known major physical, psychological, or social
risks associated with participation in this study. However, there may be unforeseen
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risks associated with participation. Lesser risks can be explained if the subjects
desire this information. Subjects should not expect their medical conditions to
improve by participation in this study. If the subjects wish, the experimenter can
provide a referral for additional assistance.
10. Attematives to Partidpatioa in the Study: Participation is voluntary. Subjects
who choose not to participate w ill attend their clinic as usual.
11. Subject Removal: There are no foreseeable circumstances under which eligible
subjects would be removed from the study against their wishes.
12. Subject's Right to Refuse to Participate or Withdraw: Study subjects may
refuse to participate or withdraw from the study at any time without jeopardizing, in
any way, their medical treatment at this institution in the present or the future.
Should significant new Andings develop during the course of the research which may
relate to the subject's willingness to continue participation, that information will be
provided to the subject.
13. Subjects Right to Privacy: The results of the study may be published, released
to a funding agency or presented in a scholarly fashion (e.g., at a conference). The
privacy and confidentiality of subjects w ill be protected, and they w ill not be
identified in any way.
14. Release of information: The medical records related to the study are available
to the experimenter. By agreeing to participate in this research study and by signing
the consent form, the subject gives permission for his/her attending medical staff to
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release relevant medical infonnation(e.g., diagnoses, medications, rate of clinic
attendance) to the experimenter.
15.

Financial Information:
A. Participation in this study will not result in any extra charges above and
beyond those routinely incurred by patients with similar illnesses.

B.

The costs of the study related to unforeseen complications must be met

by subjects.
C. Subject payment: Subjects will be paid $5.00 for participation in
the study.
16. Signatures: The study has been discussed with me and all my questions have
been answered. I understand that additional questions regarding the study should be
directed to investigators listed on page one of this consent form. I understand that if
I have questions about subjects rights, or other concerns, I can contact Dr. Perry G.
Rigby, Chancellor, at (504)568-4801. I agree with the terms above and acknowledge
1 have been given a copy of the consent form.

Signature of Subject

Date

Signature of Witness

Date
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